News | Radiation Oncology | July 17, 2019

CMS Proposes New Alternative Payment Model for Radiation Oncology

ASTRO issues statement emphasizing need for radiation oncologists to participate in value-based cancer care

CMS Proposes New Alternative Payment Model for Radiation Oncology

July 17, 2019 — The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM) for radiation oncology on July 10, 2019. In response, the American Society for Radiation Oncology (ASTRO) issued the following statement from Paul Harari, M.D., FASTRO, chair of the ASTRO Board of Directors:

“The Radiation Oncology (RO) Model announced today by the Center for Medicare and Medicaid Innovation (Innovation Center) is a step forward in allowing the nation’s 4,500 radiation oncologists to participate in the transition to value-based care that improves outcomes for cancer patients. We believe that once implemented with modifications, the model will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure,” Harari said.

“We look forward to providing comments on the specifics of the model, including requirements for certain radiation oncology groups to participate. In our comments to CMS, ASTRO will prioritize recommendations that achieve our longstanding payment reform goals, including stable and fair payments accompanied by incentives for higher quality care and lower costs. In addition, ASTRO will look closely for opportunities to ensure the model is consistent with the administration’s initiative to reduce physician burden and paperwork,” he continued.

“ASTRO has worked for many years to craft a viable payment model that would stabilize payments, drive adherence to nationally-recognized clinical guidelines and improve patient care. We appreciate the Administration’s focus and commitment to ensuring radiation oncologists' ability to participate in an advanced APM,” Harari concluded. 

Read the full proposed alternative payment model from CMS.

For more information: www.astro.org

Related Content

Surging Demand for Image-guided, Stereotactic Radiation Therapy Driving Fiducial Marker Growth
News | Radiation Therapy | August 22, 2019
As fiducial markers gain traction in parallel to rising incidences of various cancer affecting lung, prostate, abdomen...
Videos | Treatment Planning | August 21, 2019
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and
First Cancer Patient Treated With Accuray Radixact System With Synchrony Motion Tracking
News | Image Guided Radiation Therapy (IGRT) | August 21, 2019
Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have...
Videos | Patient Positioning Radiation Therapy | August 21, 2019
This is a quick demonstration of the Varian Identify image-guided patient positioning system at the...
Videos | Treatment Planning | August 21, 2019
This is a lung cancer tumor radiotherapy...
Videos | Computed Tomography (CT) | August 21, 2019
This is a quick walk around of a mobile 32-slice...
First GammaTile Therapy Case Completed in Arizona
News | Radiation Therapy | August 19, 2019
HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a...
Drug Accelerates Blood System's Recovery After Radiation, Chemotherapy

Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications

News | Radiation Therapy | August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem...